Printer Friendly

CNS, INC. REPORTS THIRD QUARTER SALES AND EARNINGS

 CNS, INC. REPORTS THIRD QUARTER SALES AND EARNINGS
 MINNEAPOLIS, Oct. 22 /PRNewswire/ -- CNS, Inc. (NASDAQ: CNXS) of


Minneapolis today reported third quarter sales and earnings. For the third quarter ended Sept. 30, 1992, the company reported sales of $2,063,547 compared to $2,019,948 for the same period of 1991. Net earnings for the quarter were $51,432 or $.01 per share compared to a net loss of $288,816 or $.08 per share for the comparable third quarter of 1991.
 For the nine months ended Sept. 30, 1992, sales were $5,306,288, down from $6,529,409 for the corresponding nine months of 1991. A net loss of $714,589 or $.12 per share was reported for the nine month period of 1992 versus a net loss of $446,716 or $.13 per share for the comparable nine month period of 1991.
 Daniel E. Cohen, M.D., chief executive officer, said, "Improved results from the previous quarter were due to an increase in sales in both domestic and international markets. Earnings were also positively impacted by cost reduction measures taken earlier this year."
 CNS, Inc. designs, manufactures and markets computer-based medical diagnostic devices used principally to test for sleep-related disorders such as sleep apnea, insomnia and narcolepsy.
 CNS, INC.
 FINANCIAL HIGHLIGHTS
 (Unaudited)
 Three Months Ended Nine Months Ended
 9/30/92 9/30/91 9/30/92 9/30/91
 Sales $2,063,547 $2,019,948 $5,306,288 $6,529,409
 Net earnings (loss) $51,432 $(288,816) $(714,589) $(446,716)
 Net earnings (loss)
 per common and common
 equivalent shares $.01 $(.08) $(.12) $(.13)
 Weighted average number
 of common and common
 equivalent shares
 outstanding 6,558,692 3,456,170 5,999,887 3,440,933
 -0- 10/22/92
 /CONTACT: Daniel E. Cohen, CNS chief executive officer, 612-474-7600/
 (CNXS) CO: CNS, Inc. ST: Minnesota IN: MTC CPR SU: ERN


KH -- MN002 -- 3335 10/22/92 09:07 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1992
Words:326
Previous Article:CACI ANNOUNCES FY93 FIRST QUARTER RESULTS REVENUE AND EARNINGS UP
Next Article:SYBRON CHEMICAL INDUSTRIES INC. ANNOUNCES QUARTERLY EPS BEFORE EXTRAORDINARY ITEMS INCREASED 50 PERCENT
Topics:


Related Articles
CNS REPORTS 1991 ANNUAL SALES AND LOSSES
CNS REPORTS FIRST QUARTER RESULTS
CNS, INC. REPORTS THIRD QUARTER SALES AND EARNINGS
CNS, INC. REPORTS THIRD QUARTER RESULTS
CNS, INC., REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER
CNS, Inc. to Exceed Third-Quarter Earnings Estimate; Results Mark a Return To Profitability.
CNS, Inc. Reports Second-Quarter Sales Up 19 Percent, EPS Grows 16 Percent; -- Six-Month Sales Rise 19 Percent; Year-to-Date EPS Up 36 Percent.
CNS Reports Growth in 2003 Third Quarter and Nine Months.
CNS, Inc. Reports Strong Fiscal 2005 Third-Quarter Results.
[CORRECTED] CNS, Inc. Reports Strong Fiscal 2005 Third-Quarter Results.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters